ClinConnect ClinConnect Logo
Search / Trial NCT06893809

Epidural Anesthesia for Transurethral Resection of The Prostate

Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · Mar 18, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

Transurethral Resection Of The Prostate Epidural Anesthesia

ClinConnect Summary

In urological procedures, the preferred anaesthetic modalities may be topical, regional or general. The decision is made by the anaesthesiologists based on patient age, sex, general condition and the surgical procedure to be performed. Transurethral procedures are frequently applied to geriatric patients, who are more likely to have comorbidities. In such cases, epidural anaesthesia may be preferred for geriatric patients.

In this study, we utilised various routes for the administration of local anaesthetics to induce epidural anaesthesia in patients scheduled for transurethral resection o...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Male undergoing transurethral prostatic resection,
  • 40 to 75 years old,
  • ASA-I-III
  • Not using anticoagulants or antiaggregants,
  • No peripheral neuropathy or muscle disease,
  • Can be orientated and co-operated,
  • No vertebral deformity,
  • Body Mass Index \<30,
  • Patients consenting to epidural anaesthesia.
  • Exclusion Criteria:
  • TUR-P operation will not be male,
  • Female patients,
  • ASA-IV,
  • Not in the appropriate age range (40-75),
  • Taking anticoagulants or antiaggregants, Previous lumbar surgery or skeletal deformity in the lumbar region,
  • Peripheral neuropathy, neuromuscular or neuropsychiatric disease,
  • Alcohol or drug addiction,
  • Obese with a body mass index \>30,
  • History of frequent analgesic use,
  • Patients shorter than 155 cm and taller than 180 cm,
  • Who refused epidural anaesthesia,
  • Patients without orientation and co-operation.

About Başakşehir çam & Sakura City Hospital

Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.

Locations

Ankara, Altındağ, Turkey

Patients applied

0 patients applied

Trial Officials

NERMİN GÖĞÜŞ, Prof.Dr.

Study Chair

Ankara City Hospital Bilkent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported